Clinical trial
Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow
NCT00003838 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00003838 |
|---|---|
| Title | Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow |
| Official title | Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients With Debilitating Hematologic Diseases |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia |
| Intervention type | Drug, Procedure |
| Interventions | T-cell replete PBPC allograft, Methotrexate, Cyclosporine, G-CSF |
| Enrollment | 202 |
| Start date | Apr 15, 1999 |
| Primary completion | Dec 14, 2018 |
| Completion | Jun 18, 2020 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 21, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: